Tolerability testing of an antioxidant-containing skin care cream on patients with atopic dermatitis

Not Applicable

• Conditions: Other atopic dermatitis; L20.8

• Registration Number: DRKS00028914
• Lead Sponsor: Charité Campus Charité Mitte

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-03-31
• Study Start: 2022-05-11
• Results First Posted: 2022-05-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

atopic dermatitis

Exclusion Criteria

food allergies

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoint: Assessment of itching, skin moisture and skin barrier for visit 1.<br>Placebo: no change in parameters.<br>Cream with plant extract improves the parameters for itching, skin moisture and skin barrier.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoint is a comparison of scores for itch, skin hydration, and skin barrier.